We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH
RNS Number : 0217D
Dechra Pharmaceuticals PLC
21 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or DECHRA PHARMACEUTICALS the underlying issuer PLC of existing shares to which voting rights are attached: (ii) ------------------------------------------------------ ------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------- An acquisition or disposal of voting rights ü ------------------------------------------------------- ----------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------- ----------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------- ----------------------- An event changing the breakdown of voting rights ------------------------------------------------------- ----------------------- Other (please specify): ----------------------------------------------------- ----------------------- 3. Full name of person(s) FMR LLC subject to the notification obligation: (iii) ------------------------------------------------------ ------------------------ 4. Full name of shareholder(s) See Section 9 (if different from 3.):(iv) ------------------------------------------------------ ------------------------ 5. Date of the transaction 19 April 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------ ------------------------ 6. Date on which issuer 21 April 2017 notified: ------------------------------------------------------ ------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 10% ------------------------------------------------------ ------------------------ 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ---------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- ---------------- ---------------- -------------- ----------------------- ------------------------- Indirect Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ -------------- --------- ------------ ------------ ----------- GB0009633180 9,309,883 9,309,883 9,315,883 9,315,883 10.00% ---------------- ---------------- -------------- --------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ -------------- -------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ---------------- -------------- -------------- ---------------- ------------------------- ----------------------- Nominal Delta ---------------- -------------- -------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 9,315,883 10.00% ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------------------------ Controlled Undertaking Percentage Holding FIAM LLC 0.11 FIDELITY MANAGEMENT & RESEARCH (JAPAN) LIMITED 0.05 FMR CO., INC 8.82 FMR INVESTMENT MANAGEMENT (UK) LIMITED 1.02 Grand Total 10.00 ---------------------------------------- ------------------- ------------------------------------------------------------------------------------------------ Proxy Voting: ------------------------------------------------------------------------------------------------ 10. Name of the proxy holder: ------------------------------------------------------------------ ---------------------------- 11. Number of voting rights proxy holder will acquire/ cease to hold: ------------------------------------------------------------------ ---------------------------- 12. Date on which proxy holder will acquire/ cease to hold voting rights: ------------------------------------------------------------------ ---------------------------- 13. Additional information: N/A ---------------------------------------------------------------- ------------------------------ 14. Contact name: Sally-Ann Hatton ---------------------------------------------------------------- ------------------------------ 15. Contact telephone number: fil-regreporting@fil.com, 01737 837148 ---------------------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGMGZDFMMGNZM
(END) Dow Jones Newswires
April 21, 2017 09:03 ET (13:03 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions